Literature DB >> 23813966

Sorting receptor SORLA--a trafficking path to avoid Alzheimer disease.

Thomas E Willnow1, Olav M Andersen.   

Abstract

Excessive proteolytic breakdown of the amyloid precursor protein (APP) to neurotoxic amyloid β peptides (Aβ) by secretases in the brain is a molecular cause of Alzheimer disease (AD). According to current concepts, the complex route whereby APP moves between the secretory compartment, the cell surface and endosomes to encounter the various secretases determines its processing fate. However, the molecular mechanisms that control the intracellular trafficking of APP in neurons and their contribution to AD remain poorly understood. Here, we describe the functional elucidation of a new sorting receptor SORLA that emerges as a central regulator of trafficking and processing of APP. SORLA interacts with distinct sets of cytosolic adaptors for anterograde and retrograde movement of APP between the trans-Golgi network and early endosomes, thereby restricting delivery of the precursor to endocytic compartments that favor amyloidogenic breakdown. Defects in SORLA and its interacting adaptors result in transport defects and enhanced amyloidogenic processing of APP, and represent important risk factors for AD in patients. As discussed here, these findings uncovered a unique regulatory pathway for the control of neuronal protein transport, and provide clues as to why defects in this pathway cause neurodegenerative disease.

Entities:  

Keywords:  APP; Alzheimer disease; Protein transport; Retromer; VPS10-domain receptors

Mesh:

Substances:

Year:  2013        PMID: 23813966     DOI: 10.1242/jcs.125393

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  47 in total

Review 1.  Dysregulation of Rab5-mediated endocytic pathways in Alzheimer's disease.

Authors:  Wei Xu; Fang Fang; Jianqing Ding; Chengbiao Wu
Journal:  Traffic       Date:  2018-02-05       Impact factor: 6.215

2.  Dual-tagged amyloid-β precursor protein reveals distinct transport pathways of its N- and C-terminal fragments.

Authors:  Christine Villegas; Virgil Muresan; Zoia Ladescu Muresan
Journal:  Hum Mol Genet       Date:  2013-11-07       Impact factor: 6.150

3.  Adaptor Protein-1 Complex Affects the Endocytic Trafficking and Function of Peptidylglycine α-Amidating Monooxygenase, a Luminal Cuproenzyme.

Authors:  Mathilde L Bonnemaison; Nils Bäck; Megan E Duffy; Martina Ralle; Richard E Mains; Betty A Eipper
Journal:  J Biol Chem       Date:  2015-07-13       Impact factor: 5.157

4.  SorLA complement-type repeat domains protect the amyloid precursor protein against processing.

Authors:  Arnela Mehmedbasic; Sofie K Christensen; Jonas Nilsson; Ulla Rüetschi; Camilla Gustafsen; Annemarie Svane Aavild Poulsen; Rikke W Rasmussen; Anja N Fjorback; Göran Larson; Olav M Andersen
Journal:  J Biol Chem       Date:  2014-12-18       Impact factor: 5.157

5.  Altered Cholesterol Intracellular Trafficking and the Development of Pathological Hallmarks of Sporadic AD.

Authors:  Xuesong Chen; Liang Hui; Mahmoud L Soliman; Jonathan D Geiger
Journal:  J Parkinsons Dis Alzheimers Dis       Date:  2014

6.  A membrane proximal helix in the cytosolic domain of the human APP interacting protein LR11/SorLA deforms liposomes.

Authors:  Richard L Gill; Xingsheng Wang; Fang Tian
Journal:  Biochim Biophys Acta       Date:  2014-05-24

7.  α(2A) adrenergic receptor promotes amyloidogenesis through disrupting APP-SorLA interaction.

Authors:  Yunjia Chen; Yin Peng; Pulin Che; Mary Gannon; Yin Liu; Ling Li; Guojun Bu; Thomas van Groen; Kai Jiao; Qin Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-17       Impact factor: 11.205

Review 8.  Biomarker modelling of early molecular changes in Alzheimer's disease.

Authors:  Ross W Paterson; Jamie Toombs; Catherine F Slattery; Jonathan M Schott; Henrik Zetterberg
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

9.  An alternative transcript of the Alzheimer's disease risk gene SORL1 encodes a truncated receptor.

Authors:  Jenny Blechingberg; Annemarie Svane Aavild Poulsen; Mads Kjølby; Giulia Monti; Mariet Allen; Anne Kathrine Ivarsen; Sarah J Lincoln; Gangadaar Thotakura; Christian B Vægter; Nilüfer Ertekin-Taner; Anders Nykjær; Olav M Andersen
Journal:  Neurobiol Aging       Date:  2018-06-28       Impact factor: 4.673

Review 10.  Binding Sites for Amyloid-β Oligomers and Synaptic Toxicity.

Authors:  Levi M Smith; Stephen M Strittmatter
Journal:  Cold Spring Harb Perspect Med       Date:  2017-05-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.